Get the app!
Back to Trades

Sessa Capital (Master), L.P.

DirectorCIK 0001618360

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
2
Buy transactions
0
Sell transactions
0
Companies
1
Active
2025

Across 2 filings between 2025, Sessa Capital (Master), L.P., Director, has disclosed $68.5M in transactions — all concentrated in SAB Biotherapeutics, Inc. (SABS). Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

2 loaded
Oct 1SABS
SAB Biotherapeutics, Inc.
Sessa Capital (Master), L.P.DirectorExercise$3.1M
Jul 24SABS
SAB Biotherapeutics, Inc.
Sessa Capital (Master), L.P.DirectorAward$65.4M

2 filings